
Big Real-World Study Finds Hair-Loss Drugs Do Not Increase Heart Disease Risk
A retrospective TriNetX study of 24,424 androgenetic alopecia patients on finasteride or dutasteride found no increased risk of composite cardiovascular disease or most individual events over 1–5 years; atrial fibrillation risk was lower at 5 years, with other outcomes not significantly different after correction. Limitations include potential confounding and uncertain adherence, but results support CV safety of these drugs in appropriately selected patients.













